the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study focused on the effect of Danhong injection on microcirculation in the treatment of patients with STEMI(ST-elevation myocardical infarction) after the PTCA surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beijing Bozhiyin T&S Co., Ltd.
• Treatments: Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Clinically definite or laboratory-supported diagnosis of STEMI ,with the indication of PTCA surgery.

• 18≤Age≤75;

• Agreed to join in the study and signed the inform consent form.

Exclusion Criteria:

• Cardiogenic shock , Killip III-IV degree , papillary muscle rupture , septal perforation , episodes of ventricular tachycardia and ventricular fibrillation after electrical cardioversion , temporary pacemaker implanted AVB III degree.

• Past history of PCI and CABG

• Acute or chronic infectious diseases(for example severe pneumonia);

• Recent history of hemorrhagic stroke(within six months)

• Combined with liver and kidney dysfunction;

• History of valvular heart disease;

• Congenital heart disease or Pulmonary hypertension;

• All kinds of history of cardiomyopathy;

• Bleeding and other thrombotic diseases;

• Severe anemia , thrombocytopenia , Other diseases of the blood system;

• Cancer , Autoimmune disease , All kinds of the patients who use the glucocorticoid and immunosuppressor;

• Menstrual period women, pregnant women and lactating women, pregnancy test positive or recent family planning.